Kalaari Capital

Kalaari Capital is one of India’s most established early-stage technology funds, with a long-running thesis around transformative digital businesses including healthcare AI and digital health platforms. The firm’s confirmed portfolio in this space includes HealthPlix, the Bangalore-based EMR platform that has scaled to 12,000+ doctors, alongside other AI-enabled healthcare bets such as Pype AI. Stage focus is seed and Series A with checks in the $1M to $5M range, and AI is an explicit area of investment, including healthcare AI, medical devices, and health software. The right founder for Kalaari is an Indian technical founder, often with deep operator credentials, building defensible AI or software for clinical, diagnostic, or care-coordination workflows with B2B distribution to providers, payers, or pharma. The wrong founder is a consumer wellness brand without B2B traction, an early biotech team needing scientific syndicate construction, or a US-based founder using India as an engineering satellite. Intro paths run through Bangalore’s deep operator network, the IIT and IISc alumni systems, frequent co-investors including Sequoia, Lightspeed India, Accel India, Chiratae, and Blume, and through Kalaari’s own portfolio CEOs. Vani Kola, Rajesh Raju, and other partners are publicly active and discoverable. Cold inbound is read but warm intros from credible operators are materially more effective. In the pitch, lead with the data moat and the model performance evidence, since Kalaari’s diligence on AI is sharper than the average Indian fund and weak claims will be priced down. Show specific provider deployment patterns, real outcome or efficiency metrics from pilots, and a credible plan to compound proprietary clinical data over time. Be explicit about CDSCO posture for any device-classified software, about NMC implications for clinical decision support, and about the rapidly evolving Indian regulatory environment around AI in healthcare. Show that you understand the difference between Indian and US healthcare data realities, particularly the absence of standardized claims data, and how that shapes what AI is actually possible. Caveats are minor: Kalaari is a strong partner with brand, follow-on capacity, and downstream signaling, but the Indian Series A market is competitive and timelines have compressed. Founders who arrive with shipped product, real customer signal, and a defensible technical narrative get the most out of this partnership.